Form SCHEDULE 13G/A Galecto, Inc. Filed by: Ikarian Capital, LLC

March 6, 2026 4:43 PM EST





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The figures in Items 6, 8, and 9 represent common stock, $0.00001 par value per share ("Common Stock") of Galecto, Inc. (the "Issuer") held by Ikarian Healthcare Master Fund, L.P., a Cayman Islands exempted limited partnership (the "Fund"), and certain separate managed accounts. See Item 2 for more information. (2) The figure in Item 11 is based upon 60,232,620 shares of Common Stock outstanding as of February 12, 2026, as disclosed in the Issuer's Prospectus and current report on Form 8-K, each filed with the U.S. Securities and Exchange Commission (the "SEC") on February 11, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The figures in Items 6, 8, and 9 represent Common Stock held by the Fund and certain separate managed accounts. See Item 2 for more information. (2) The figure in Item 11 is based upon 60,232,620 shares of Common Stock outstanding as of February 12, 2026, as disclosed in the Issuer's Prospectus and current report on Form 8-K, each filed with the SEC on February 11, 2026.


SCHEDULE 13G



 
Ikarian Capital, LLC
 
Signature:/s/ Neil Shahrestani
Name/Title:Neil Shahrestani, Sole Manager
Date:03/06/2026
 
Neil Shahrestani
 
Signature:/s/ Neil Shahrestani
Name/Title:Neil Shahrestani
Date:03/06/2026

Comments accompanying signature:   A Joint Filing Agreement is incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed on December 5, 2025 by the Reporting Persons with the SEC.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G